These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 12461704
1. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ambresin A, Tran T, Spertini F, Herbort C. Ocul Immunol Inflamm; 2002 Mar; 10(1):53-63. PubMed ID: 12461704 [Abstract] [Full Text] [Related]
2. [Ocular manifestations in Behçet's disease]. Desbois AC, Terrada C, Cacoub P, Bodaghi B, Saadoun D. Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716 [Abstract] [Full Text] [Related]
3. Spectrum of Behçet's disease in the Indian population. Sachdev N, Kapali N, Singh R, Gupta V, Gupta A. Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879 [Abstract] [Full Text] [Related]
4. Prognostic comparison of Behçet's disease with or without HLA-Bw 51 antigen. Kim MS, Kim JH. Korean J Ophthalmol; 1989 Dec; 3(2):85-9. PubMed ID: 2635747 [Abstract] [Full Text] [Related]
12. [Characteristics of ocular involvement in Behçet disease in Tunisia: Monocentric study and review of literature]. Ajili F, Bellakhal S, Ben Abdelhafidh N, Mrabet A, Zouari B, Maalej A, Louzir B, Laabidi J, Othmani S. Pathol Biol (Paris); 2015 Apr; 63(2):85-90. PubMed ID: 25434793 [Abstract] [Full Text] [Related]
13. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis]. Zlatanović G, Jovanović S, Veselinović D, Zivković M. Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372 [Abstract] [Full Text] [Related]